Skip to main content
Erschienen in: Endocrine 1/2017

15.10.2016 | Review

Association of parathyroid carcinoma and thyroid disorders: A clinical review

verfasst von: Alfredo Campennì, Salvatore Giovinazzo, Salvatore Antonio Pignata, Francesca Di Mauro, Domenico Santoro, Lorenzo Curtò, Francesco Trimarchi, Rosaria Maddalena Ruggeri, Sergio Baldari

Erschienen in: Endocrine | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Parathyroid carcinoma is a rare malignancy, which usually occurs as a sporadic disease, and less frequently in the setting of genetic syndromes. Despite the association of parathyroid and thyroid disorders being quite common, the coexistence of parathyroid carcinoma and thyroid disease is rare. We reviewed the pertinent literature. The terms “parathyroid carcinoma” and “thyroid disease, hyperthyroidism, thyrotoxicosis, hypothyroidism, thyroid nodule(s), Graves’ disease, autonomously functioning thyroid nodules” were used both separately and in reciprocal conjunction to search MEDLINE for articles published from January 2007 to March 2016. The search was prompted by the observation of a never reported association of autonomously functioning thyroid nodules and parathyroid carcinoma. Two hundred and twenty-one parathyroid carcinoma patients have been described during the last 10 years. Neck ultrasonography and parathyroid scintigraphy are the most common instrumental studies used in detecting parathyroid lesions. Serum parathyroid hormone and calcium levels are high in the majority of parathyroid carcinoma patients. Only 21 patients with parathyroid carcinoma and thyroid disorders were found. Our patient is the first casual association between parathyroid carcinoma and autonomously functioning thyroid nodules reported in literature and diagnosed using parathyroid and thyroid scintigraphies. Parathyroid carcinoma is a very rare endocrine tumor and association with thyroid disease is not frequent. Parathyroid carcinoma pre-operative diagnosis is often difficult also because available literature data are not homogenous and there is not a common operative guideline. Our case confirms the role of parathyroid scintigraphy, encouraging the association with thyroid scintigraphy, especially in the presence of (multi)-nodular goiter in order to address the most appropriate surgical management.
Literatur
1.
Zurück zum Zitat E. Shane, Clinical review 122: Parathyroid carcinoma. J. Clin. Endocrinol. Metab. 86, 485–493 (2001)CrossRefPubMed E. Shane, Clinical review 122: Parathyroid carcinoma. J. Clin. Endocrinol. Metab. 86, 485–493 (2001)CrossRefPubMed
2.
Zurück zum Zitat N. Talat, K.M. Schulte, Clinical presentation, staging and long-term evolution of parathyroid cancer. Ann. Surg. Oncol. 17, 2156–2174 (2010)CrossRefPubMed N. Talat, K.M. Schulte, Clinical presentation, staging and long-term evolution of parathyroid cancer. Ann. Surg. Oncol. 17, 2156–2174 (2010)CrossRefPubMed
3.
Zurück zum Zitat F. Cetani, E. Pardi, C. Marcocci, Update on parathyroid carcinoma. J. Endocrinol. Invest. 39, 595–606 (2016)CrossRefPubMed F. Cetani, E. Pardi, C. Marcocci, Update on parathyroid carcinoma. J. Endocrinol. Invest. 39, 595–606 (2016)CrossRefPubMed
4.
Zurück zum Zitat A. Agha, R. Carpenter, S. Bhattacharya, S.J. Edmonson, E. Carlsen, J.P. Monson, Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognised entity. J. Endocrinol. Invest. 30, 145–149 (2007)CrossRefPubMed A. Agha, R. Carpenter, S. Bhattacharya, S.J. Edmonson, E. Carlsen, J.P. Monson, Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognised entity. J. Endocrinol. Invest. 30, 145–149 (2007)CrossRefPubMed
5.
Zurück zum Zitat A. Campennì, R.M. Ruggeri, A. Sindoni, S. Giovinazzo, L. Calbo, A. Ieni, M. Monaco, G. Tuccari, S. Benvenga, S. Baldari, Parathyroid carcinoma as a challenging diagnosis: report of three cases. Hormones (Athens) 3, 368–376 (2012)CrossRef A. Campennì, R.M. Ruggeri, A. Sindoni, S. Giovinazzo, L. Calbo, A. Ieni, M. Monaco, G. Tuccari, S. Benvenga, S. Baldari, Parathyroid carcinoma as a challenging diagnosis: report of three cases. Hormones (Athens) 3, 368–376 (2012)CrossRef
6.
Zurück zum Zitat A. Campennì, R.M. Ruggeri, A. Sindoni, S. Giovinazzo, E. Calbo, A. Ieni, L. Calbo, G. Tuccari, S. Baldari, S. Benvenga, Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism. J. Bone Miner. Metab. 3, 367–372 (2012)CrossRef A. Campennì, R.M. Ruggeri, A. Sindoni, S. Giovinazzo, E. Calbo, A. Ieni, L. Calbo, G. Tuccari, S. Baldari, S. Benvenga, Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism. J. Bone Miner. Metab. 3, 367–372 (2012)CrossRef
7.
Zurück zum Zitat F. Cetani, G. Frustaci, L. Torregrossa, S. Magno, F. Basolo, A. Campomori, P. Miccoli, C. Marcocci, A non-functioning parathyroid carcinoma misdiagnosed as a follicular thyroid nodule. World J. Surg. Oncol. (2015). doi:10.1186/s12957-015-0672-9 F. Cetani, G. Frustaci, L. Torregrossa, S. Magno, F. Basolo, A. Campomori, P. Miccoli, C. Marcocci, A non-functioning parathyroid carcinoma misdiagnosed as a follicular thyroid nodule. World J. Surg. Oncol. (2015). doi:10.​1186/​s12957-015-0672-9
8.
Zurück zum Zitat F. Aghini-Lombardi, P. Vitti, L. Antonangeli, E. Fiore, A. Piaggi, E. Consiglio, A. Pinchera, Southern Italy study group for iodine deficiency disorders: The size of the community rather than its geographical location better defines the risk of iodine deficiency: results of an extensive survey in Southern Italy. J. Endocrinol. Invest. 36, 282–286 (2013)CrossRefPubMed F. Aghini-Lombardi, P. Vitti, L. Antonangeli, E. Fiore, A. Piaggi, E. Consiglio, A. Pinchera, Southern Italy study group for iodine deficiency disorders: The size of the community rather than its geographical location better defines the risk of iodine deficiency: results of an extensive survey in Southern Italy. J. Endocrinol. Invest. 36, 282–286 (2013)CrossRefPubMed
9.
Zurück zum Zitat T.M. Vicchio, S. Giovinazzo, R. Certo, M. Cucinotta, C. Micali, S. Baldari, S. Benvenga, F. Trimarchi, A. Campennì, R.M. Ruggeri, Lack of association between autonomously functioning thyroid nodules and germline polymorphisms of the thyrotropin receptor and Gas genes in a mild to moderate iodine-deficient Caucasian population. J. Endocrinol. Invest. 7, 625–630 (2014)CrossRef T.M. Vicchio, S. Giovinazzo, R. Certo, M. Cucinotta, C. Micali, S. Baldari, S. Benvenga, F. Trimarchi, A. Campennì, R.M. Ruggeri, Lack of association between autonomously functioning thyroid nodules and germline polymorphisms of the thyrotropin receptor and Gas genes in a mild to moderate iodine-deficient Caucasian population. J. Endocrinol. Invest. 7, 625–630 (2014)CrossRef
10.
Zurück zum Zitat I.D. Hay, J.D. Morris. Toxic adenoma and toxic multinodular goiter. Werner and Ingbar’s The Thyroid. L.E. Braverman, R.D. Utiger (Lippincott-Raven, Philadelphia, 1996), pp. 566–572 I.D. Hay, J.D. Morris. Toxic adenoma and toxic multinodular goiter. Werner and Ingbar’s The Thyroid. L.E. Braverman, R.D. Utiger (Lippincott-Raven, Philadelphia, 1996), pp. 566–572
11.
Zurück zum Zitat M. Kebapci, E. Entok, N. Kebapci, B. Adapinar, Preoperative evaluation of parathyroid lesions in patients with concomitant thyroid disease: role of high resolution ultrasonography and dual phase technetium 99m sestamibi scintigraphy. J. Endocrinol. Invest. 27, 24–30 (2004)CrossRefPubMed M. Kebapci, E. Entok, N. Kebapci, B. Adapinar, Preoperative evaluation of parathyroid lesions in patients with concomitant thyroid disease: role of high resolution ultrasonography and dual phase technetium 99m sestamibi scintigraphy. J. Endocrinol. Invest. 27, 24–30 (2004)CrossRefPubMed
12.
Zurück zum Zitat S. Tseleni-Balafouta, H. Gakiopoulou, N. Kavantzas, G. Agrogiannis, N. Givalos, E. Patsouris, Parathyroid proliferations: a source of diagnostic pitfalls in FNA of thyroid. Cancer 111, 130–136 (2007)CrossRefPubMed S. Tseleni-Balafouta, H. Gakiopoulou, N. Kavantzas, G. Agrogiannis, N. Givalos, E. Patsouris, Parathyroid proliferations: a source of diagnostic pitfalls in FNA of thyroid. Cancer 111, 130–136 (2007)CrossRefPubMed
13.
Zurück zum Zitat H. Mazeh, D. Prus, H.R. Freund, Incidental non-functional parathyroid carcinoma identified during thyroidectomy. Isr. Med. Assoc. J. 10, 659 (2008)PubMed H. Mazeh, D. Prus, H.R. Freund, Incidental non-functional parathyroid carcinoma identified during thyroidectomy. Isr. Med. Assoc. J. 10, 659 (2008)PubMed
14.
Zurück zum Zitat M. Goldfarb, P. O’Neal, J.L. Shih, P. Hartzband, J. Connolly, P.O. Hasselgren, Synchronous parathyroid carcinoma, parathyroid adenoma, and papillary thyroid carcinoma in a patient with severe and long-standing hyperparathyroidism. Endocr. Pract. 15, 463–468 (2009)CrossRefPubMedPubMedCentral M. Goldfarb, P. O’Neal, J.L. Shih, P. Hartzband, J. Connolly, P.O. Hasselgren, Synchronous parathyroid carcinoma, parathyroid adenoma, and papillary thyroid carcinoma in a patient with severe and long-standing hyperparathyroidism. Endocr. Pract. 15, 463–468 (2009)CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat P.Y. Marcy, J. Thariat, A. Sudaka, G. Poissonnet, Synchronous parathyroid and papillary thyroid carcinomas. Thyroid 19, 1131–1133 (2009)CrossRefPubMed P.Y. Marcy, J. Thariat, A. Sudaka, G. Poissonnet, Synchronous parathyroid and papillary thyroid carcinomas. Thyroid 19, 1131–1133 (2009)CrossRefPubMed
16.
Zurück zum Zitat L. Chaychi, K. Belbruno, A. Golding, V. Memoli, Unusual manifestation of parathyroid carcinoma in the setting of papillary thyroid cancer. Endocr. Pract. 16, 664–668 (2010)CrossRefPubMed L. Chaychi, K. Belbruno, A. Golding, V. Memoli, Unusual manifestation of parathyroid carcinoma in the setting of papillary thyroid cancer. Endocr. Pract. 16, 664–668 (2010)CrossRefPubMed
17.
Zurück zum Zitat H.A. Amoodi, F.M. Makki, S. Mark Taylor, M.J. Bullock, R.D. Hart, J.R. Trites, Synchronous thyroid/parathyroid carcinomas. J. Otolaryngol. Head Neck Surg. 39, 42–47 (2010) H.A. Amoodi, F.M. Makki, S. Mark Taylor, M.J. Bullock, R.D. Hart, J.R. Trites, Synchronous thyroid/parathyroid carcinomas. J. Otolaryngol. Head Neck Surg. 39, 42–47 (2010)
18.
Zurück zum Zitat S.I. Basceken, V. Genc, S. Ersoz, Y. Sevim, S.U. Celik, I.K. Bayram, Is local resection sufficient for parathyroid carcinoma? Clinics (Sao Paulo) 70, 247–249 (2015)CrossRef S.I. Basceken, V. Genc, S. Ersoz, Y. Sevim, S.U. Celik, I.K. Bayram, Is local resection sufficient for parathyroid carcinoma? Clinics (Sao Paulo) 70, 247–249 (2015)CrossRef
19.
Zurück zum Zitat M. Zakerkish, E. Rajaei, M. Dargahi, M. Bahadoram, A rare constellation of Hürthle cell thyroid carcinoma and parathyroid carcinoma. J. Clin. Diagn. Res. 9, 8–10 (2015) M. Zakerkish, E. Rajaei, M. Dargahi, M. Bahadoram, A rare constellation of Hürthle cell thyroid carcinoma and parathyroid carcinoma. J. Clin. Diagn. Res. 9, 8–10 (2015)
20.
Zurück zum Zitat J.N. Talbot, F. Duron, T. Kiffel, B. Nordlinger, Association of parathyroid adenoma and autonomous nodule of the thyroid. Diagnostic efficacy of 201thallium-99mtechnetium scintigraphy. Eur. J. Nucl. Med. 12, 304–305 (1986)CrossRefPubMed J.N. Talbot, F. Duron, T. Kiffel, B. Nordlinger, Association of parathyroid adenoma and autonomous nodule of the thyroid. Diagnostic efficacy of 201thallium-99mtechnetium scintigraphy. Eur. J. Nucl. Med. 12, 304–305 (1986)CrossRefPubMed
21.
Zurück zum Zitat D.J. Bentrem, P. Angelos, M.S. Talamonti, R. Nayar, Is preoperative investigation of the thyroid justified in patients undergoing parathyroidectomy for hyperparathyroidism? Thyroid 12, 1109–1112 (2002)CrossRefPubMed D.J. Bentrem, P. Angelos, M.S. Talamonti, R. Nayar, Is preoperative investigation of the thyroid justified in patients undergoing parathyroidectomy for hyperparathyroidism? Thyroid 12, 1109–1112 (2002)CrossRefPubMed
22.
Zurück zum Zitat E. Hindié, Ö. Ugur, D. Fuster, M. O’Doherty, G. Grassetto, A. Ureña Kettle, S.A. Gulec, F. Pons, D. Rubello, EANM parathyroid guidelines. Eur. J. Nucl. Med. Mol. Imaging 7, 1201–1216 (2009)CrossRef E. Hindié, Ö. Ugur, D. Fuster, M. O’Doherty, G. Grassetto, A. Ureña Kettle, S.A. Gulec, F. Pons, D. Rubello, EANM parathyroid guidelines. Eur. J. Nucl. Med. Mol. Imaging 7, 1201–1216 (2009)CrossRef
23.
Zurück zum Zitat L. Foppiani, P. Del Monte, G. Sartini, A. Arlandini, P. Quilici, R. Bandelloni, A. Marugo, D. Bernasconi, Intrathyroidal parathyroid carcinoma as cause of hypercalcemia and pitfall of localization techniques: clinical and biologic features. Endocr. Pract. 13, 176–181 (2007)CrossRefPubMed L. Foppiani, P. Del Monte, G. Sartini, A. Arlandini, P. Quilici, R. Bandelloni, A. Marugo, D. Bernasconi, Intrathyroidal parathyroid carcinoma as cause of hypercalcemia and pitfall of localization techniques: clinical and biologic features. Endocr. Pract. 13, 176–181 (2007)CrossRefPubMed
24.
Zurück zum Zitat G.G. Fernandez-Ranvier, E. Khanafshar, K. Jensen, R. Zarnegar, J. Lee, E. Kebebew, Q.Y. Duh, O.H. Clark, Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis? Cancer 110, 255–264 (2007)CrossRefPubMed G.G. Fernandez-Ranvier, E. Khanafshar, K. Jensen, R. Zarnegar, J. Lee, E. Kebebew, Q.Y. Duh, O.H. Clark, Parathyroid carcinoma, atypical parathyroid adenoma, or parathyromatosis? Cancer 110, 255–264 (2007)CrossRefPubMed
25.
Zurück zum Zitat I. Kruljac, I. Pavic, N. Matesa, G. Mirosevic, A. Maric, B. Becejac, M. Ivkic, D. Zadravec, K. Katinic, M. Vrkljan, Intrathyroid parathyroid carcinoma with intrathyroidal metastasis to the contralateral lobe: source of diagnostic and treatment pitfalls. Jpn. J. Clin. Oncol. 41, 1142–1146 (2011)CrossRefPubMed I. Kruljac, I. Pavic, N. Matesa, G. Mirosevic, A. Maric, B. Becejac, M. Ivkic, D. Zadravec, K. Katinic, M. Vrkljan, Intrathyroid parathyroid carcinoma with intrathyroidal metastasis to the contralateral lobe: source of diagnostic and treatment pitfalls. Jpn. J. Clin. Oncol. 41, 1142–1146 (2011)CrossRefPubMed
26.
Zurück zum Zitat L. Vila Duckworth, W.E. Winter, M. Vaysberg, C.A. Moran, S.Z. Al-Quran, Intrathyroidal parathyroid carcinoma: report of an unusual case and review of the literature. Case Rep. Pathol. (2013). doi:10.1155/2013/198643 L. Vila Duckworth, W.E. Winter, M. Vaysberg, C.A. Moran, S.Z. Al-Quran, Intrathyroidal parathyroid carcinoma: report of an unusual case and review of the literature. Case Rep. Pathol. (2013). doi:10.​1155/​2013/​198643
27.
Zurück zum Zitat M. Diaconescu, M. Glod, I. Costea, M. Grigorovici, S. Diaconescu, Thyroid and thymic exeresis in surgery of hyperparathyroidism. Chirurgia (Bucur) 109, 747–752 (2014) M. Diaconescu, M. Glod, I. Costea, M. Grigorovici, S. Diaconescu, Thyroid and thymic exeresis in surgery of hyperparathyroidism. Chirurgia (Bucur) 109, 747–752 (2014)
28.
Zurück zum Zitat J. Cao, C. Chen, Q.L. Wang, J.J. Xu, M.H. Ge, Parathyroid carcinoma: a report of six cases with a brief review of the literature. Oncol. Lett. 10, 3363–3368 (2015)PubMedPubMedCentral J. Cao, C. Chen, Q.L. Wang, J.J. Xu, M.H. Ge, Parathyroid carcinoma: a report of six cases with a brief review of the literature. Oncol. Lett. 10, 3363–3368 (2015)PubMedPubMedCentral
29.
Zurück zum Zitat K.S. Beus, B.C. Stack Jr, Synchronous thyroid pathology in patients presenting with primary hyperparathyroidism. Am. J. Otolaryngol. 5, 308–312 (2004)CrossRef K.S. Beus, B.C. Stack Jr, Synchronous thyroid pathology in patients presenting with primary hyperparathyroidism. Am. J. Otolaryngol. 5, 308–312 (2004)CrossRef
30.
Zurück zum Zitat H. Savli, A. Sevinc, R. Sari, S. Ozen, S. Buyukberber, E. Ertas, Occult parathyroid carcinoma in a patient with papillary thyroid carcinoma and Hashimoto’s thyroiditis. J. Endocrinol. Invest. 1, 42–44 (2001)CrossRef H. Savli, A. Sevinc, R. Sari, S. Ozen, S. Buyukberber, E. Ertas, Occult parathyroid carcinoma in a patient with papillary thyroid carcinoma and Hashimoto’s thyroiditis. J. Endocrinol. Invest. 1, 42–44 (2001)CrossRef
31.
Zurück zum Zitat I.D. Kirkwood, B.E. Chatterton, P. Malycha, S. Guha, Autonomous thyroid adenoma, papillary thyroid carcinoma, and ectopic parathyroid adenoma in a patient with primary hyperparathyroidism and a nontoxic multinodular goiter. Clin. Nucl. Med. 7, 491–493 (1997)CrossRef I.D. Kirkwood, B.E. Chatterton, P. Malycha, S. Guha, Autonomous thyroid adenoma, papillary thyroid carcinoma, and ectopic parathyroid adenoma in a patient with primary hyperparathyroidism and a nontoxic multinodular goiter. Clin. Nucl. Med. 7, 491–493 (1997)CrossRef
32.
Zurück zum Zitat He Y., S. Liu, H. Guo, B. Shi, Incidental finding of papillary thyroid carcinoma with BRAFV600E mutation in a patient with coexistent primary hyperparathyroidism and Graves’ hyperthyroidism. BMJ Case Rep. (2014). doi:10.1136/bcr-2013-203436 He Y., S. Liu, H. Guo, B. Shi, Incidental finding of papillary thyroid carcinoma with BRAFV600E mutation in a patient with coexistent primary hyperparathyroidism and Graves’ hyperthyroidism. BMJ Case Rep. (2014). doi:10.​1136/​bcr-2013-203436
33.
Zurück zum Zitat S. Wei, Z.W. Baloch, V.A. LiVolsi, Parathyroid adenoma in patients with Graves’ disease: a report of 21 cases. Endocr. Pathol. 1, 71–74 (2015)CrossRef S. Wei, Z.W. Baloch, V.A. LiVolsi, Parathyroid adenoma in patients with Graves’ disease: a report of 21 cases. Endocr. Pathol. 1, 71–74 (2015)CrossRef
34.
Zurück zum Zitat C. Verdelli, I. Forno, V. Vaira, S. Corbetta, Epigenetic alterations in human parathyroid tumors. Endocrine 49, 324–332 (2015)CrossRefPubMed C. Verdelli, I. Forno, V. Vaira, S. Corbetta, Epigenetic alterations in human parathyroid tumors. Endocrine 49, 324–332 (2015)CrossRefPubMed
35.
Zurück zum Zitat F. De Quervain, Parastruma maligna aberrata. Deutsche Zeitschr. Chir. 100, 334–352 (1904)CrossRef F. De Quervain, Parastruma maligna aberrata. Deutsche Zeitschr. Chir. 100, 334–352 (1904)CrossRef
36.
Zurück zum Zitat K.S. Beus, B.C. Stack Jr, Parathyroid carcinoma. Otolaryngol. Clin. North Am. 37, 845–854 (2004)CrossRefPubMed K.S. Beus, B.C. Stack Jr, Parathyroid carcinoma. Otolaryngol. Clin. North Am. 37, 845–854 (2004)CrossRefPubMed
37.
Zurück zum Zitat J.P. Givi, Shah parathyroid carcinoma. Clin. Oncol. (R. Coll. Radiol.) 22, 498–507 (2010)CrossRef J.P. Givi, Shah parathyroid carcinoma. Clin. Oncol. (R. Coll. Radiol.) 22, 498–507 (2010)CrossRef
38.
Zurück zum Zitat C.H. Wei, A. Harari, Parathyroid carcinoma: update and guidelines for management. Curr. Treat. Options Oncol. 1, 11–23 (2012)CrossRef C.H. Wei, A. Harari, Parathyroid carcinoma: update and guidelines for management. Curr. Treat. Options Oncol. 1, 11–23 (2012)CrossRef
39.
Zurück zum Zitat F. Medas, E. Erdas, G. Loi, F. Podda, G. Pisano, A. Nicolosi, P.G. Calò, Controversies in the management of parathyroid carcinoma: a case series and review of the literature. Int. J. Surg. 28, 94–98 (2016)CrossRef F. Medas, E. Erdas, G. Loi, F. Podda, G. Pisano, A. Nicolosi, P.G. Calò, Controversies in the management of parathyroid carcinoma: a case series and review of the literature. Int. J. Surg. 28, 94–98 (2016)CrossRef
40.
Zurück zum Zitat M. Halenka, D. Karasek, Z. Frysak, Four ultrasound and clinical pictures of parathyroid carcinoma. Case Rep. Endocrinol. (2012) doi:10.1155/2012/363690 M. Halenka, D. Karasek, Z. Frysak, Four ultrasound and clinical pictures of parathyroid carcinoma. Case Rep. Endocrinol. (2012) doi:10.​1155/​2012/​363690
41.
Zurück zum Zitat A. Bhansali, S.R. Masoodi, S. Bhadaba, B.R. Mittal, A. Behra, P. Singh, Ultrasonography in detection of single and multiple abnormal parathyroid glands in primary hyperparathyroidism: comparison Clin. Endocrinol. (Oxf.) 65, 340–345 (2006)CrossRef A. Bhansali, S.R. Masoodi, S. Bhadaba, B.R. Mittal, A. Behra, P. Singh, Ultrasonography in detection of single and multiple abnormal parathyroid glands in primary hyperparathyroidism: comparison Clin. Endocrinol. (Oxf.) 65, 340–345 (2006)CrossRef
42.
Zurück zum Zitat R. Ersoy, O. Ersoy, B. Evranos Ogmen, S.B. Polat, M. Kilic, N. Yildirim, L. Ozturk, B. Cakir, Diagnostic value of endoscopic ultrasonography for preoperative localization of parathyroid adenomas. Endocrine 47, 221–226 (2014)CrossRefPubMed R. Ersoy, O. Ersoy, B. Evranos Ogmen, S.B. Polat, M. Kilic, N. Yildirim, L. Ozturk, B. Cakir, Diagnostic value of endoscopic ultrasonography for preoperative localization of parathyroid adenomas. Endocrine 47, 221–226 (2014)CrossRefPubMed
43.
Zurück zum Zitat L. Giovanella, A. Campenni, G. Treglia, F.A. Verburg, P. Trimboli, L. Ceriani, M. Bongiovanni, Molecular imaging with (99m)Tc-MIBI and molecular testing for mutations in differentiating benign from malignant follicular neoplasm: a prospective comparison. Eur. J. Nucl. Med. Mol. Imaging 43, 1018–1026 (2016)CrossRefPubMed L. Giovanella, A. Campenni, G. Treglia, F.A. Verburg, P. Trimboli, L. Ceriani, M. Bongiovanni, Molecular imaging with (99m)Tc-MIBI and molecular testing for mutations in differentiating benign from malignant follicular neoplasm: a prospective comparison. Eur. J. Nucl. Med. Mol. Imaging 43, 1018–1026 (2016)CrossRefPubMed
44.
Zurück zum Zitat A. Campenni, L. Giovanella, M. Siracusa, A. Alibrandi, S. Pignata, S. Giovinazzo, F. Trimarchi, R.M. Ruggeri, S. Baldari, 99mTc-methoxy-isobutyl-isonitrile (MIBI) scintigraphy is a useful tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC). Thyroid 26, 1101–1109 (2016)CrossRefPubMed A. Campenni, L. Giovanella, M. Siracusa, A. Alibrandi, S. Pignata, S. Giovinazzo, F. Trimarchi, R.M. Ruggeri, S. Baldari, 99mTc-methoxy-isobutyl-isonitrile (MIBI) scintigraphy is a useful tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC). Thyroid 26, 1101–1109 (2016)CrossRefPubMed
45.
Zurück zum Zitat D. Rubello, G. Saladini, D. Casara, N. Borsato, A. Toniato, A. Piotto, P. Bernante, M.R. Pelizzo, Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy: a fast and effective technique. Clin. Nucl. Med. 7, 527–531 (2000)CrossRef D. Rubello, G. Saladini, D. Casara, N. Borsato, A. Toniato, A. Piotto, P. Bernante, M.R. Pelizzo, Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy: a fast and effective technique. Clin. Nucl. Med. 7, 527–531 (2000)CrossRef
46.
Zurück zum Zitat F.Y. Tseng, Y.L. Hsiao, T.C. Chang, Ultrasound-guided fine needle aspiration cytology of parathyroid lesions. A review of 72 cases. Acta Cytol. 46, 1029–1036 (2002)CrossRefPubMed F.Y. Tseng, Y.L. Hsiao, T.C. Chang, Ultrasound-guided fine needle aspiration cytology of parathyroid lesions. A review of 72 cases. Acta Cytol. 46, 1029–1036 (2002)CrossRefPubMed
47.
Zurück zum Zitat D. Abraham, P.K. Sharma, J. Bentz, P.M. Gault, L. Neumayer, D.A. McClain, Utility of ultrasound-guided fine-needle aspiration of parathyroid adenomas for localization before minimally invasive parathyroidectomy. Endocr. Pract. 13, 333–337 (2007)CrossRefPubMed D. Abraham, P.K. Sharma, J. Bentz, P.M. Gault, L. Neumayer, D.A. McClain, Utility of ultrasound-guided fine-needle aspiration of parathyroid adenomas for localization before minimally invasive parathyroidectomy. Endocr. Pract. 13, 333–337 (2007)CrossRefPubMed
48.
Zurück zum Zitat I. Heo, S. Park, C.W. Jung, J.S. Koh, S.S. Lee, H. Seol, H.S. Choi, S.Y. Cho, Fine needle aspiration cytology of parathyroid lesions. Korean J. Pathol. 47, 466–471 (2013)CrossRefPubMedPubMedCentral I. Heo, S. Park, C.W. Jung, J.S. Koh, S.S. Lee, H. Seol, H.S. Choi, S.Y. Cho, Fine needle aspiration cytology of parathyroid lesions. Korean J. Pathol. 47, 466–471 (2013)CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat I. Bancos, C.S. Grant, S. Nadeem, M.N. Stan, C.C. Reading, T.J. Sebo, A. Algeciras-Schimnich, R.J. Singh, D.S. Dean, Risks and benefits of parathyroid fine-needle aspiration with parathyroid hormone washout. Endocr. Pract. 18, 441–449 (2012)CrossRefPubMed I. Bancos, C.S. Grant, S. Nadeem, M.N. Stan, C.C. Reading, T.J. Sebo, A. Algeciras-Schimnich, R.J. Singh, D.S. Dean, Risks and benefits of parathyroid fine-needle aspiration with parathyroid hormone washout. Endocr. Pract. 18, 441–449 (2012)CrossRefPubMed
50.
Zurück zum Zitat C. Spinelli, A.G. Bonadio, P. Berti, G. Materazzi, P. Miccoli, Cutaneous spreading of parathyroid carcinoma after fine needle aspiration cytology. J. Endocrinol. Invest. 23, 255–257 (2000)CrossRefPubMed C. Spinelli, A.G. Bonadio, P. Berti, G. Materazzi, P. Miccoli, Cutaneous spreading of parathyroid carcinoma after fine needle aspiration cytology. J. Endocrinol. Invest. 23, 255–257 (2000)CrossRefPubMed
Metadaten
Titel
Association of parathyroid carcinoma and thyroid disorders: A clinical review
verfasst von
Alfredo Campennì
Salvatore Giovinazzo
Salvatore Antonio Pignata
Francesca Di Mauro
Domenico Santoro
Lorenzo Curtò
Francesco Trimarchi
Rosaria Maddalena Ruggeri
Sergio Baldari
Publikationsdatum
15.10.2016
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2017
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-016-1147-7

Weitere Artikel der Ausgabe 1/2017

Endocrine 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.